It was the latter discovery – and not the hotly debated Danish study per se – that led Prof. Dyker to conclude that the yellow batches might be "something like placebos", after all. But the third slide from the interview also deserves to be better known, since it refocuses attention on a crucial aspect of this story which has been almost completely obscured amidst the sound and fury of the attempted 'debunkings' of the placebo hypothesis: namely, the relationship between the regulator, the Paul Ehrlich Institute, and the manufacturer, Germany's BioNTech.